Decorin fragments and methods of inhibiting cell regulatory factors
CA 2132859 A1 · Owner: La Jolla Cancer Research Foundation · Inventors: Pierschbacher, Michael D.; Craig, William; Mullen, Daniel G.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides a method of inhibiting an activity of a cell regulatory factor comprising contacting the cell regulatory factor with a purified polypeptide wherein the polypeptide, comprises a cell regulatory factor binding domain of a protein. The protein is characterized by a leucine-rich repeat of about 24 amino acids. In a specific embodiment, the present invention relates to the ability of decorin, a 40,000 dalton protein that usually carries a glycosaminoglycan chain and more specifically to, active fragments of decorin or its functional equivalents to bind TGF.beta.. The invention also provides a cell regulatory factor designated MRF. Also provided are methods of …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed April 2, 1993. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended April 2, 2013.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 2, 2015.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.